Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Call for Abstracts
    • 2022 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
  • Log out
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Archives
    • Most-Read Papers of 2022
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2023 Call for Abstracts
    • 2022 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
Research ArticleOriginal Research

Hypercapnic Respiratory Failure in Obesity-Hypoventilation Syndrome: CO2 Response and Acetazolamide Treatment Effects

Joan-Maria Raurich, Gemma Rialp, Jordi Ibáñez, Juan Antonio Llompart-Pou and Ignacio Ayestarán
Respiratory Care November 2010, 55 (11) 1442-1448;
Joan-Maria Raurich
Intensive Care Unit, Hospital Universitari Son Dureta, Palma de Mallorca, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Gemma Rialp
Son Llàtzer Hospital, Palma de Mallorca, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordi Ibáñez
Intensive Care Unit, Hospital Universitari Son Dureta, Palma de Mallorca, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juan Antonio Llompart-Pou
Intensive Care Unit, Hospital Universitari Son Dureta, Palma de Mallorca, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ignacio Ayestarán
Intensive Care Unit, Hospital Universitari Son Dureta, Palma de Mallorca, Spain.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

OBJECTIVE: In obesity-hypoventilation-syndrome patients mechanically ventilated for hypercapnic respiratory failure we investigated the relationship between CO2 response, body mass index, and plasma bicarbonate concentration, and the effect of acetazolamide on bicarbonate concentration and CO2 response.

METHODS: CO2 response tests and arterial blood gas analysis were performed in 25 patients ready for a spontaneous breathing test, and repeated in a subgroup of 8 patients after acetazolamide treatment. CO2 response test was measured as (1) hypercapnic drive response (the ratio of the change in airway occlusion pressure 0.1 s after the start of inspiratory flow to the change in PaCO2), and (2) hypercapnic ventilatory response (the ratio of the change in minute volume to the change in PaCO2).

RESULTS: We did not find a significant relationship between CO2 response and body mass index. Patients with higher bicarbonate concentration had a more blunted CO2 response. Grouping the patients according to the first, second, and third tertiles of the bicarbonate concentration, the hypercapnic drive response was 0.32 ± 0.17 cm H2O/mm Hg, 0.22 ± 0.15 cm H2O/mm Hg, and 0.10 ± 0.06 cm H2O/mm Hg, respectively (P = .01), and hypercapnic ventilatory response was 0.46 ± 0.23 L/min/mm Hg, 0.48 ± 0.36 L/min/mm Hg, and 0.22 ± 0.16 L/min/mm Hg, respectively (P = .04). After acetazolamide treatment, bicarbonate concentration was reduced by 8.4 ± 3.0 mmol/L (P = .01), and CO2 response was shifted to the left, with an increase in hypercapnic drive response, by 0.14 ± 0.16 cm H2O/mm Hg (P = .02), and hypercapnic ventilatory response, by 0.11 ± 0.22 L/min/mm Hg (P = .33).

CONCLUSIONS: Patients with obesity-hypoventilation syndrome and higher bicarbonate concentrations had a more blunted CO2 response. Body mass index was not related to CO2 response. Acetazolamide decreased bicarbonate concentration and increased CO2 response.

  • obesity-hypoventilation syndrome
  • hypercapnia
  • mechanical ventilation
  • respiratory center
  • respiratory function test
  • acetazolamide
  • metabolic alkalosis

Footnotes

  • Correspondence: Joan Maria Raurich MD, Intensive Care Unit, Hospital Universitari Son Dureta, Andrea Doria 55, 07014, Palma de Mallorca, Illes Balears, Spain. E-mail: joan.raurich{at}ssib.es.
  • The authors have disclosed no conflicts of interest.

  • See the Related Editorial on Page 1504

  • Copyright © 2010 by Daedalus Enterprises Inc.
PreviousNext
Back to top

In this issue

Respiratory Care: 55 (11)
Respiratory Care
Vol. 55, Issue 11
1 Nov 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

 

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hypercapnic Respiratory Failure in Obesity-Hypoventilation Syndrome: CO2 Response and Acetazolamide Treatment Effects
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Hypercapnic Respiratory Failure in Obesity-Hypoventilation Syndrome: CO2 Response and Acetazolamide Treatment Effects
Joan-Maria Raurich, Gemma Rialp, Jordi Ibáñez, Juan Antonio Llompart-Pou, Ignacio Ayestarán
Respiratory Care Nov 2010, 55 (11) 1442-1448;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Hypercapnic Respiratory Failure in Obesity-Hypoventilation Syndrome: CO2 Response and Acetazolamide Treatment Effects
Joan-Maria Raurich, Gemma Rialp, Jordi Ibáñez, Juan Antonio Llompart-Pou, Ignacio Ayestarán
Respiratory Care Nov 2010, 55 (11) 1442-1448;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Keywords

  • obesity-hypoventilation syndrome
  • hypercapnia
  • mechanical ventilation
  • respiratory center
  • respiratory function test
  • acetazolamide
  • metabolic alkalosis

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire